255 related articles for article (PubMed ID: 12970025)
21. [Pleural amyloidosis: thoracoscopic diagnosis and physiopathological approach].
Astoul P; Cheikh R; Cabanot C; Vialette JP; Vestri R; Boutin C
Rev Mal Respir; 1992; 9(6):629-31. PubMed ID: 1470756
[TBL] [Abstract][Full Text] [Related]
22. [Cardiac amyloidosis. A case report].
Butcovan D; Arsenescu C; Pintilie D; Dabija E; Dabija A; Georgescu GI
Rev Med Chir Soc Med Nat Iasi; 2005; 109(1):46-9. PubMed ID: 16607826
[TBL] [Abstract][Full Text] [Related]
23. Right ventricular function in AL amyloidosis: characteristics and prognostic implication.
Cappelli F; Porciani MC; Bergesio F; Perlini S; Attanà P; Moggi Pignone A; Salinaro F; Musca F; Padeletti L; Perfetto F
Eur Heart J Cardiovasc Imaging; 2012 May; 13(5):416-22. PubMed ID: 22180463
[TBL] [Abstract][Full Text] [Related]
24. [Primary amyloidosis AL as a cause of restrictive cardiomyopathy].
Rückert Y; Hansen A; Dörffel WV; Eckert B; Scholze J
Z Kardiol; 1997 Oct; 86(10):812-7. PubMed ID: 9454448
[TBL] [Abstract][Full Text] [Related]
25. Cardiac amyloidosis.
Nadkar MY; Pandit AP; Bamburde SH; Singh R
J Assoc Physicians India; 2008 Dec; 56():992-4. PubMed ID: 19322982
[TBL] [Abstract][Full Text] [Related]
26. Treatment of diuretic refractory pleural effusions with bevacizumab in four patients with primary systemic amyloidosis.
Hoyer RJ; Leung N; Witzig TE; Lacy MQ
Am J Hematol; 2007 May; 82(5):409-13. PubMed ID: 17326106
[TBL] [Abstract][Full Text] [Related]
27. [Amyloidosis and pleural calcification].
Leleu O; Clarot C; Renaud H; Brahimi M; Lelarge C; Makdassi R
Rev Mal Respir; 2003 Sep; 20(4):618-21. PubMed ID: 14528167
[TBL] [Abstract][Full Text] [Related]
28. [Chronic heart failure in patients with cardiac amyloidosis].
Solomakhina NI; Varshavskiĭ VA; Gundarova LV; Golitsina EP; Shchekochikhin DIu
Klin Med (Mosk); 2009; 87(3):26-30. PubMed ID: 19469251
[TBL] [Abstract][Full Text] [Related]
29. Prevalence of symptomatic large pleural effusions first diagnosed more than 30 days after coronary artery bypass graft surgery.
Peng MC; Hou CJ; Li JY; Hu PY; Chen CY
Respirology; 2007 Jan; 12(1):122-6. PubMed ID: 17207037
[TBL] [Abstract][Full Text] [Related]
30. Serial echocardiographic observations in patients with primary systemic amyloidosis: an introduction to the concept of early (asymptomatic) amyloid infiltration of the heart.
Cueto-Garcia L; Tajik AJ; Kyle RA; Edwards WD; Greipp PR; Callahan JA; Shub C; Seward JB
Mayo Clin Proc; 1984 Sep; 59(9):589-97. PubMed ID: 6471919
[TBL] [Abstract][Full Text] [Related]
31. Atypical Pleural Fluid Profiles in Tuberculous Pleural Effusion: Sequential Changes Compared with Parapneumonic and Malignant Pleural Effusions.
Kim CH; Lee SY; Lee YD; Yoo SS; Lee SY; Cha SI; Park JY; Lee J
Intern Med; 2016; 55(13):1713-9. PubMed ID: 27374670
[TBL] [Abstract][Full Text] [Related]
32. [Pleural amyloidosis].
Sun Y; Xu W; Luo W
Zhonghua Jie He He Hu Xi Za Zhi; 1997 Aug; 20(4):212-4. PubMed ID: 10072804
[TBL] [Abstract][Full Text] [Related]
33. [A case of systemic primary amyloidosis with BHL and M-protein in pleural effusion].
Tsuchiya Y; Shimokata K; Sasou H; Ichikawa M
Nihon Kyobu Shikkan Gakkai Zasshi; 1993 May; 31(5):624-8. PubMed ID: 8331850
[TBL] [Abstract][Full Text] [Related]
34. Amyloidosis diagnosed in cytology specimen of pleural effusion: A case report.
Manur R; Lamzabi I
Diagn Cytopathol; 2018 Jun; 46(6):522-524. PubMed ID: 29280335
[TBL] [Abstract][Full Text] [Related]
35. [Pleural amyloidosis. Apropos of a case and review of the literature].
Quinquenel ML; Le Coz A; Desrues B; Caulet-Maugendre S; Lena H; Belleguic C; Lineau C; Delaval P
Rev Pneumol Clin; 1996; 52(1):39-41. PubMed ID: 8731756
[TBL] [Abstract][Full Text] [Related]
36. Right ventricular dilation in primary amyloidosis: an independent predictor of survival.
Patel AR; Dubrey SW; Mendes LA; Skinner M; Cupples A; Falk RH; Davidoff R
Am J Cardiol; 1997 Aug; 80(4):486-92. PubMed ID: 9285663
[TBL] [Abstract][Full Text] [Related]
37. [Amyloid cardiomyopathy: a link between cardiology and hematology. A case report of positive response to standard therapy].
Petrillo G; Catalano L; Petruzziello F; Padula S; Petrillo C; Caso P
G Ital Cardiol (Rome); 2007 Jun; 8(6):371-6. PubMed ID: 17633911
[TBL] [Abstract][Full Text] [Related]
38. Cardiac changes in systemic amyloidosis: visualisation by magnetic resonance imaging.
Cheng AS; Banning AP; Mitchell AR; Neubauer S; Selvanayagam JB
Int J Cardiol; 2006 Oct; 113(1):E21-3. PubMed ID: 17049635
[TBL] [Abstract][Full Text] [Related]
39. Pleural fluid cell-free DNA in parapneumonic pleural effusion.
Santotoribio JD; Cabrera-Alarcón JL; Batalha-Caetano P; Macher HC; Guerrero JM
Clin Biochem; 2015 Oct; 48(15):1003-5. PubMed ID: 26234638
[TBL] [Abstract][Full Text] [Related]
40. Pentraxin-3: A novel biomarker for discriminating parapneumonic from other exudative effusions.
Ozsu S; Abul Y; Mentese A; Bektas H; Uzun A; Ozlu T; Porcel JM
Respirology; 2013 May; 18(4):657-62. PubMed ID: 23286371
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
